Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Premium Crops is a leading specialist arable crop provider based in the United Kingdom, focusing on the production and supply of high-value specialty seeds and oils for the pharmaceutical, nutraceutical, and industrial sectors. The company manages a vertically integrated supply chain, contracting with farmers to grow specific varieties of crops such as High Erucic Acid Rapeseed (HEAR), borage, and evening primrose. These crops are processed to extract essential fatty acids like Gamma-linolenic acid (GLA), which are utilized as active ingredients in treatments for skin disorders and inflammatory conditions. As a subsidiary of Cefetra Group, Premium Crops combines agricultural expertise with biotechnological applications to deliver traceable, high-quality plant-based raw materials to global life science markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Premium Crops.